Letter to Editor: F.S. Kaplan, et al., Early clinical observations on the use of imatinibmesylate in FOP: A report of seven cases, Bone (2017)
| Autor: | Ondrej Slaby, Rohleder O, Peter Múdry, Hana Nosková, Jakub Neradil, Jaroslav Sterba |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Histology Physiology business.industry Sunitinib Endocrinology Diabetes and Metabolism Dermatology 3. Good health 03 medical and health sciences 030104 developmental biology 0302 clinical medicine 030220 oncology & carcinogenesis Medicine business medicine.drug |
| Zdroj: | Bone. 116:171 |
| ISSN: | 8756-3282 |
| DOI: | 10.1016/j.bone.2018.08.003 |
| Popis: | We read with great interest the article published by F.S. Kaplan et al. Early clinical observations on the use of imatinibmesylate in FOP: A report of seven cases, Bone (2017). Following this [1] we would like to present a case report of one our patient with FOP successfully responding to sunitinib. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect